Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19

BACKGROUND: There is no proven antiviral or immunomodulatory therapy for coronavirus disease 2019 (COVID-19). The disease progression associated with the proinflammatory host response prompted us to examine the role of early corticosteroid therapy in patients with moderate to severe COVID-19. METHOD...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Main Authors: Fadel, Raef, Morrison, Austin R, Vahia, Amit, Smith, Zachary R, Chaudhry, Zohra, Bhargava, Pallavi, Miller, Joseph, Kenney, Rachel M, Alangaden, George, Ramesh, Mayur S
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Articles and Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314133/
https://ncbi.nlm.nih.gov/pubmed/32427279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa601
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares